Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2025-12-25 @ 12:01 PM
Study NCT ID:
NCT04687761
Status:
UNKNOWN
Last Update Posted:
2022-09-08
First Post:
2020-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
Sponsor:
PETHEMA Foundation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-17
First Submit QC Date:
None
Study First Post Date:
2020-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-07
Last Update Post Date:
2022-09-08
Last Update Post Date Type:
ACTUAL